This inventor holds 1 USPTO granted patent. Top assignee: Afyx Development A/s. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Per Holm and Intranasal Ketamine for Cluster Headache
Introduction
Per Holm is an inventor associated with Vanløse, Denmark. His patent work addresses a potential treatment approach for Cluster Headache, including chronic Cluster Headache. Holm is associated with Afyx Development A/S and has 1 patent listed in the information provided.
Latest Patents
Holm’s listed patent, “Intranasal Administration of Ketamine to Cluster Headache Patients,” describes treating patients with Cluster Headache through intranasal administration of an aqueous composition containing a therapeutically effective amount of ketamine. The composition may be delivered in a nasal dosage form, such as a nasal spray. The patent description proposes that this approach may reduce or eliminate ketamine-related side effects when used to treat Cluster Headache.
Career Highlights
Holm’s documented innovation focuses on a nasal ketamine formulation for Cluster Headache treatment. His work is associated with Afyx Development A/S.
Collaborations
The information provided names Ole Pedersen and John Claude Krusz as Holm’s coworkers.
Conclusion
Per Holm’s listed patent explores intranasal ketamine as a potential treatment option for Cluster Headache, reflecting his contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile